Literature DB >> 12062643

Chromatographic determination of the association constants between nimesulide and native and modified beta-cyclodextrins.

Corinne Ravelet1, Annabelle Geze, Annick Villet, Catherine Grosset, Anne Ravel, Denis Wouessidjewe, Eric Peyrin.   

Abstract

The retention of a non-steroidal anti-inflammatory drug (NSAID), i.e. nimesulide, in high performance liquid chromatography (HPLC) was investigated using a phenyl bond silica column and beta-cyclodextrin (beta-CD) or hydroxypropyl-beta-cyclodextrin (HP-beta-CD) as mobile phase additive (0-10 mM). Such a study was carried out in order to determine the most efficient cyclodextrin as a potential drug complexing agent for a future application in pharmaceutical formulation. Assuming a 1:1 stoichiometry, the association constants (K) were calculated from the chromatographic data. At a column temperature of 25 degrees C and in a highly aqueous medium (98% phosphate buffer-2% methanol (v/v)), K was equal to 523 and 1285 M(-1) for the nimesulide-beta-CD and nimesulide HP-beta-CD complexes, respectively. These results were consistent with the data reported previously using phase solubility studies and UV spectrophotometry. As well, the thermodynamic parameters of the inclusion complexes were determined from linear van't Hoff plots for the two inclusion complexes. From the enthalpy and entropy changes, it appeared that nimesulide interact more strongly with HP-beta-CD due to a significant hydrophobic effect between the compound and the flexible hydroxypropyl groups.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12062643     DOI: 10.1016/s0731-7085(02)00088-2

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  1 in total

1.  Investigation of Combined Cyclodextrin and Hydrogel Formulation for Ocular Delivery of Dexamethasone Acetate by Means of Experimental Designs.

Authors:  Roseline Mazet; Luc Choisnard; Delphine Levilly; Denis Wouessidjewe; Annabelle Gèze
Journal:  Pharmaceutics       Date:  2018-12-01       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.